Atlas Trials

Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF)

Clinical trial NCT01349192 · TERMINATED

Trial details

NCT number
NCT01349192
Sponsor
University of North Carolina, Chapel Hill
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Cystic FibrosisMethicillin-resistant Staphylococcus Aureus
Start date
2011-04-01
Primary completion
2015-01-01
Enrollment
47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.